Scholars Central

Mini reviewPublished 30 Dec 2023

Pharmacokinetics of Vacomycin

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Vancomycin, a glycopeptide antibiotic renowned for its efficacy against gram-positive bacterial infections, has beena mainstay in the treatment of serious infections, particularly those caused by methicillin-resistant Staphylococcusaureus (MRSA). Vancomycin is primarily administered intravenously due to its negligible oral absorption. The drugexhibits a large volume of distribution, predominantly in the extracellular fluid, with limited penetration through theblood-brain barrier. Despite its significant role in combating infections, Vancomycin is not metabolized extensivelyin the body. Dosing adjustments are crucial, particularly in patients with impaired renal function, to prevent drug accumulation and associated toxicity. Extended interval dosing strategies may be employed to optimize efficacy while minimizing nephrotoxic and ototoxic risks. Special populations, including pediatric and elderly patients, as well as those with obesity, may require individualized dosing approaches.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacokinetics & Experimental Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacokinetics & Experimental Therapeutics
  • SubjectPharmaceutical Sciences

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels